8:00 - 8:30 am |
Registration Open & Continental Breakfast |
|
8:30 - 8:40 am |
Welcome |
|
8:40 - 9:55 am |
SESSION I: Advancing activity-based protein profiling |
|
|
Keriann Backus, PhD UCLA |
|
|
Ben Cravatt, PhD Scripps Research Institute |
|
|
Ekaterina (Katya) Vinogradova, PhD Rockefeller University |
|
9:55 - 10:15 am |
Session 1 Panel Discussion
|
|
10:15 -10:25 am |
Break |
|
10:25 - 11:40 am |
SESSION 2: Expanding covalency in drug design |
|
|
Paola Castaldi, PhD Matchpoint Therapeutics |
|
|
Kevan Shokat, PhD UCSF |
|
|
Jack Taunton, PhD UCSF |
|
11:40 - 12:00 pm |
Session 2 Pannel Discussion
|
|
12:00 - 1:00 pm |
Lunch |
|
1:00 - 1:30 pm |
Special MS Technology Lecture |
|
1:30 - 2:00 pm |
Lightning Trainee Talks |
|
2:00 - 2:10 pm |
Break |
|
2:10 3:25 pm |
SESSION 3: Using mass spectrometry for target and ligand discovery |
|
|
Sherry Niessen, PhD Belharra Therapeutics |
|
|
Matt Patricelli, PhD Vividion Therapeutics |
|
|
Peter Jackson, PhD Stanford University |
|
3:25 - 3:45 pm |
Session 3 Pannel Discussion
|
|
3:45 - 3:55 pm |
Break |
|
3:55 - 5:10 pm |
SESSION 4: Developing proximity-based therapeutics |
|
|
Katelyn Cassidy, PhD C4 Therapeutics |
|
|
Katherine Donovan, PhD Dana Farber Cancer Institute |
|
|
Pete Wildes, PhD Revolution Medicine |
|
5:10 - 5:30 PM |
Session 4 Panel Discussion
|
|
5:30 - 5:35 PM |
Closing remarks
|
|
5:35 - 6:15 PM |
Reception
|